Navigation Links
PharmAthene Awarded 50% Profit Split on Worldwide Sales of Smallpox Antiviral Therapy by Delaware Chancery Court
Date:9/22/2011

/a> under the "Investor Relations" tab.

Conference Call and Webcast Information

PharmAthene management will be hosting a conference call to discuss the Delaware Court of Chancery decision. The call is scheduled to begin at 9:00 a.m. on Friday, September 23, 2011, and is expected to last approximately 30 minutes. The dial-in number within the United States is 866-831-6267.  The dial-in number for international callers is 617-213-8857.  The participant passcode is 20110532.

A replay of the conference call will be available beginning at approximately midnight on Friday, September 23, 2011.  The dial-in number to access the reply from within the United States is 888-286-8010.   For international callers, the dial-in number is 617-801-6888.  The participant passcode is 67593711.

The conference call will also be webcast and can be accessed from the Company's website at www.PharmAthene.com.  A link to the webcast may be found under the Investor Relations section of the website.  

Statement on Cautionary Factors

Except for the historical information presented herein, matters discussed may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Statements that are not historical facts, including statements preceded by, followed by, or that include the words "potential"; "believe"; "anticipate"; "intend"; "plan"; "expect"; "estimate"; "could"; "may"; "should"; "will"; "project"; "potential"; or similar statements are forward-looking statements. PharmAthene disclaims any intent or obligation to update these forward-looking statements other than as required by law.  Risks and uncertainties
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. PharmAthene Announces $6.5 Million Registered Direct Offering
2. PharmAthene Completes Dosing in Valortim® Phase I Clinical Trial
3. PharmAthene Provides Update on Litigation With SIGA Technologies
4. PharmAthene Presents New Anthrax Data at the 5th Annual PHEMCE Stakeholders Workshop and BARDA Industry Day
5. PharmAthene to Host Third Quarter 2010 Conference Call and Webcast on Thursday, November 11, 2010
6. PharmAthene Announces Closing of $15 Million Public Offering
7. PharmAthene Appoints Eric I. Richman President and Chief Executive Officer
8. PharmAthene Provides Update on NYSE Amex Listing Compliance Plan
9. PharmAthene Completes Previously Announced Registered Direct Offering
10. PharmAthene Presents New Data for Lyophilized rPA Anthrax Vaccine Showing Enhanced Immunogenicity
11. PharmAthene Develops Thermostable Lyophilized rPA Anthrax Vaccine Under a Challenge Grant From the National Institutes of Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... N.Y. , Nov. 21, 2014  Cardinal Health, ... world,s largest health care services companies, and Henry Schein, ... provider of health care products and services to office-based ... the companies have entered into a long-term strategic agreement ... product offerings to office-based medical practices.  This strategic agreement ...
(Date:11/21/2014)... N.J. , Nov. 20, 2014 /PRNewswire/-- CANTEL MEDICAL CORP. (NYSE: ... Krakauer , Chief Executive Officer, will be presenting at the ... New York Palace Hotel in New York ... 2014 at 2:00 PM ET. In addition, Mr. Krakauer and ... available for separate one-on-one meetings during the day. ...
(Date:11/21/2014)... Nov. 20, 2014  The acceptance of two ... AAGL Global Congress demonstrates continued interest in the ... provide bowel control. One of the abstracts, presented by ... Division Chief of Urogynecology and Reconstructive Pelvic Surgery ... Award for Best Written Abstract on Urogynecology/Pelvic Floor ...
Breaking Medicine Technology:Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 2Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 3Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 4Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 5LIFE Study Prominently Featured at Minimally Invasive Gynecology Conference 2LIFE Study Prominently Featured at Minimally Invasive Gynecology Conference 3
... British Columbia--(BUSINESS WIRE)--Apr 3, 2007 - ... Company(TM),announced today the publication of new ... showing that Allon's product,candidate AL-108 significantly ... the hyperphosphorylation of tau protein in ...
... BASEL, Switzerland, April 3, 2007 (PRIME NEWSWIRE) ... microbiological and,pharmacokinetic profiles of Basilea's (SWX:BSLN) two ... for ceftobiprole, the first anti-MRSA broad-spectrum,cephalosporin in ... for the treatment of invasive fungal infections,yielded ...
Cached Medicine Technology:Allon Therapeutics to Present New Data at Leerink Swann Alzheimer's,Conference 2Allon Therapeutics to Present New Data at Leerink Swann Alzheimer's,Conference 3Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 2Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 3Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 4Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 5Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 6Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 7
(Date:11/22/2014)... 23, 2014 Today, Dylan Queen, a ... collection of wedding dresses; the business offers a wide ... accessories for ladies worldwide, allowing them to create multiple ... the company, this new collection of chic wedding dresses ... they are offered at discounted rates now. Dylan Queen ...
(Date:11/22/2014)... Discount-Dress.com is an important company ... is to increase the company’s online market share by a ... of bridesmaid dresses and announced a bridesmaid dress promotion for ... Dec. 30, 2014. All the dresses from this company are ... In fact, Discount-Dress.com is very good at manufacturing wedding dresses. ...
(Date:11/22/2014)... November 22, 2014 "My friend went ... caused by the machine," said an inventor from Cambria ... to go back a second time because the first ... , She developed the patent-pending MAMO EASY to offer ... The design saves the patient from the pain normally ...
(Date:11/22/2014)... The wide variety and complexity of foods served at ... food allergies, an expert warns. "Every person is ... allergies that it can be really difficult to avoid ... of allergy and clinical immunology at Wake Forest Baptist ... "If you know you have food allergies, caution should ...
(Date:11/22/2014)... month has been a historical time for Angeldress.co.uk, an excellent ... from some renowned review websites. Recently, the company has added ... selection of wonderful sexy wedding dresses to its website. At ... up to an 80% discount on any order over GBP ... suitable dress at Angeldress.co.uk, which has garnered a hard core ...
Breaking Medicine News(10 mins):Health News:Dylan Queen Introduces Its New Wedding Dresses 2Health News:Bridesmaid Dresses Introduced by Famous Company Discount-Dress.com For The New Year 2015 2Health News:'Tis the Season of Challenges for Those With Food Allergies 2Health News:Sexy Wedding Dresses with Special Discounts Launched by Angeldress.co.uk 2
... , , DENVER, Sept. 15 ... of kidney care services for those diagnosed with chronic kidney disease ... the End Stage Renal Disease (ESRD) Network,s patient quality improvement goal. ... in Virginia by promoting increased use of fistulas, thereby minimizing the ...
... found 138 sites that sold them illegally, without a prescription ... on their own that they need antibiotics can easily find ... benefit of a prescription, new research shows. , The practice ... an overuse of antibiotics that is known to create resistant ...
... , , , , ... ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products, ... Life Sciences Conference at the Grand Hyatt Hotel in New York. ... at 4:30 p.m. Eastern Time on Tuesday, September 22, 2009. , ...
... , , , PROVIDENCE, ... are invited to step forward on October 4, 2009 at ... "The Walk: Hasbro Children,s Hospital." Patients, families, hospital staff ... money to support patient care and cutting-edge pediatric research in ...
... , , , ... Inc. (Pink Sheets: ASFX) (the Company) today announced the appointment ... as Senior Vice President and Director of Business Development of ... of the intellectual property formerly owned by Safeguard, which produces ...
... , , , WASHINGTON, Sept. ... a forum held by the House Democratic Steering and Policy Committee ... are the Speaker,s remarks: , , "Good morning. ... we are closer than ever before in history to passing health ...
Cached Medicine News:Health News:New Data Shows DaVita Facilities Lead Virginia in Improving Kidney Patient Care 2Health News:Antibiotics Bought Easily on the Internet 2Health News:Antibiotics Bought Easily on the Internet 3Health News:ATS Medical to Participate at the 2009 UBS Global Life Sciences Conference 2Health News:Hasbro Children's Hospital Kicks Off Inaugural Fundraising Walk 2Health News:Hasbro Children's Hospital Kicks Off Inaugural Fundraising Walk 3Health News:American Scientific Resources, Inc. Welcomes Jason Roth 2Health News:Pelosi Remarks at Democratic Steering and Policy Committee Forum on Health Insurance Reform 2Health News:Pelosi Remarks at Democratic Steering and Policy Committee Forum on Health Insurance Reform 3
... has been developing diverse medical ... years. Our medical-surgical products have ... innovation, quality and customer satisfaction. ... the Labtron® line of diagnostic ...
... Nebulizers deliver particulate humidity in the 3 ... secretion patients. For your convenience, Thera-Mist® nebulizers ... of sterile water., ,The P30000N, for ... 20-50% with a total flow range of ...
... can be held at angles up to 45° ... in spill column, finger grooves for a non-slip ... 7 feet of regular oxygen tubing. The ... size and sustain optimum mist concentration at every ...
With ten colors available, Spectrums line of Color-Coded Fiberoptic Light Cables makes it easy to track by department....
Medicine Products: